SMAD4 and neoplasm: Activation of TGF-β receptor with subsequent enhancement of β-catenin/SMAD4 pathway leads to many processes inside the tumour cells as cell reprogramming induction, epithelial phenotyping of primary tumour cells to acquire interstitial cell characteristics and tumour cell invasion to ECM leading to tumour metastasis.15